Sandra J. De Meyer
Beerse, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model.
Journal: The New England journal of medicine
Published: November 26, 2025
Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model.
Journal: The New England journal of medicine
Published: November 26, 2025
Viral sequence analysis of chronic hepatitis B patients treated with the siRNA JNJ-73763989 in phase II clinical trials.
Journal: JHEP reports : innovation in hepatology
Published: April 03, 2025
Serum levels of hepatitis B core antibodies and hepatitis B core-related antigen at the time of nucleos(t)ide analog cessation and risk of severe flares in patients with chronic hepatitis B.
Journal: Hepatology communications
Published: October 02, 2024
The IL-6 hypothesis in COVID-19: A phase 2, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of free IL-6 sequestration by the monoclonal antibody sirukumab in severe and critical COVID-19.
Journal: The Journal of infection
Published: February 20, 2024
Genotypic and phenotypic characterization of influenza A viral variants in study participants treated with pimodivir in the phase 2b TOPAZ study.
Journal: Antiviral therapy
Published: May 25, 2023
Viral sequence analysis of chronic hepatitis B patients treated with the capsid assembly modulator JNJ-56136379 in the JADE phase 2a study.
Journal: Antiviral research
Published: March 10, 2023
Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates.
Journal: Nature
Published: June 29, 2022
Development and optimization of a high-throughput screening assay for in vitro anti-SARS-CoV-2 activity: Evaluation of 5676 Phase 1 Passed Structures.
Journal: Journal of medical virology
Published: February 02, 2022
In vitro activity of itraconazole against SARS-CoV-2.
Journal: Journal of medical virology
Published: January 14, 2021
Pooled resistance analyses of darunavir once-daily regimens and formulations across 10 clinical studies of treatment-naïve and treatment-experienced patients with human immunodeficiency virus-1 infection.
Journal: HIV research & clinical practice
Published: July 28, 2020
Last Updated: 09/26/2026